Delivery Order SPE2DB24D2105-SPE2DB24FANUJ
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Uloric 80mg tablets. The award has a ceiling value of $2,990.19 and an ultimate completion date of November 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,580.18 to AmerisourceBergen Drug Corp for the supply of Uloric 80 mg tablets (30-count units) under a firm fixed-price contract type. The award was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and is classified as a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,912.24 delivery order to AmerisourceBergen Drug Corp for Uloric 40 mg tablets (30-count) on September 19, 2025, with a completion date of September 22, 2025. This competitively awarded, firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The prime vendor agreement serves as a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide a variety of pharmaceutical products and medical supplies. The $10,517.14 firm fixed-price delivery order is for URELLE TABLET 90S and has a completion date of December 14, 2021. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of FEBUXOSTAT 80 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,378.93 firm fixed-price delivery order contract has a completion date of July 7, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,209.32 firm fixed-price delivery order is for the supply of 4561919635 URELLE TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of August 24, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,663.72 firm-fixed-price delivery order is for the supply of febuxostat 40mg tablets, a medication used to treat gout. The award has an ultimate completion date of July 14, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $4,707.58 for the supply of 4563000249 ! ALFUZOSIN HCL ER 10 MG TABLET 90S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 6, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Febuxostat 40 mg tablets. The $10,771.20 firm-fixed-price delivery order has a period of performance through February 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $94,507.14 firm fixed-price delivery order is for the supply of 1,100 mg/11 ml vials of the drug ULTOMIRIS. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB24FANUJDelivery Order
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,352.29 Firm Fixed Price delivery order contract is for the pharmaceutical product ULORIC 80 MG TABLET 30S, with a completion date of February 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation. These IDCs enable Amerisourcebergen to efficiently deliver a wide range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs. The contract award described does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/22/24 |